$0.348400
-0.04-9.72%
At close: -
$0.345000
-0.0034-0.98%
After Hours: 5:30 PM EDT
ImmunoPrecise Antibodies reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of ImmunoPrecise Antibodies using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-09-16 | $-0.11 | $-0.08 | -37.5 % |
Jun 2024 | 2024-07-29 | $-0.58 | $-0.08 | -625.0 % |
Dec 2023 | 2024-03-14 | $-0.08 | $-0.07 | -14.3 % |
Sep 2023 | 2023-12-14 | $-0.07 | $-0.10 | 26.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-09-16 | $3.87M | $4.96M | -22.0 % |
Jun 2024 | 2024-07-29 | $4.72M | $4.72M | 0.02 % |
Dec 2023 | 2024-03-14 | $4.56M | $4.50M | 1.22 % |
Sep 2023 | 2023-12-14 | $4.62M | $4.33M | 6.74 % |
ImmunoPrecise Antibodies (IPA) is scheduled to report earnings on December 12, 2024. The last reported earnings were for reported on September 16, 2024 for Q1.
The Actual EPS was $-0.11, which missed the estimate of $-0.08.
The Actual Revenue was $3.9M, which missed the estimate of $5M.
Browse earnings estimates, EPS, and revenue on all stocks.